RETRACTED: Kinase inhibitors and airway inflammation

This publication has 118 references indexed in Scilit:

• A selective novel low‐molecular‐weight inhibitor of IκB kinase‐β (IKK‐β) prevents pulmonary inflammation and shows broad anti‐inflammatory activity
  British Journal of Pharmacology, 2005
• Attenuation of Murine Collagen-Induced Arthritis by a Novel, Potent, Selective Small Molecule Inhibitor of IκB Kinase 2, TPCA-1 (2-[(Aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), Occurs via Reduction of Proinflammatory Cytokines and Antigen-Induced T Cell Proliferation
  The Journal of Pharmacology and Experimental Therapeutics, 2005
• Allergen‐induced inflammation and airway epithelial and smooth muscle cell proliferation: role of Jun N‐terminal kinase
  British Journal of Pharmacology, 2003
• The Orally Available Spleen Tyrosine Kinase Inhibitor 2-[7-(3,4-Dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide Dihydrochloride (BAY 61-3606) Blocks Antigen-Induced Airway Inflammation in Rodents
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases
  Nature Reviews Drug Discovery, 2003
• Update on glucocorticoid action and resistance
  Journal of Allergy and Clinical Immunology, 2003
• Increased expression of nuclear factor-κB in bronchial biopsies from smokers and patients with COPD
  European Respiratory Journal, 2002
• Asthma
  New England Journal of Medicine, 2001
• Activation and Localization of Transcription Factor, Nuclear Factor- κ B, in Asthma
  American Journal of Respiratory and Critical Care Medicine, 1998
• Direct interaction of Syk and Lyn protein tyrosine kinases in rat basophilic leukemia cells activated via type I Fcɛ receptors
  European Journal of Immunology, 1997